|
|
Volumn 5, Issue , 2010, Pages 403-416
|
|
Clinical effectiveness of telmisartan alone or in combination therapy for controlling blood pressure and vascular risk in the elderly.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOTENSIN 1 RECEPTOR ANTAGONIST;
ANTIHYPERTENSIVE AGENT;
BENZIMIDAZOLE DERIVATIVE;
BENZOIC ACID DERIVATIVE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;
TELMISARTAN;
AGED;
COMORBIDITY;
DRUG COMBINATION;
DRUG EFFECT;
DRUG POTENTIATION;
FEMALE;
HEART LEFT VENTRICLE HYPERTROPHY;
HUMAN;
HYPERTENSION;
MALE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
POLYPHARMACY;
PREVALENCE;
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
REVIEW;
SEX DIFFERENCE;
STROKE;
AGED;
AGED, 80 AND OVER;
ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ANTIHYPERTENSIVE AGENTS;
BENZIMIDAZOLES;
BENZOATES;
COMORBIDITY;
DIABETES MELLITUS, TYPE 2;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMANS;
HYPERTENSION;
HYPERTROPHY, LEFT VENTRICULAR;
MALE;
POLYPHARMACY;
PPAR GAMMA;
PREVALENCE;
RENIN-ANGIOTENSIN SYSTEM;
SEX FACTORS;
STROKE;
|
|
EID: 79952670636
PISSN: None
EISSN: 11781998
Source Type: Journal
DOI: 10.2147/cia.s6709 Document Type: Review |
|
Times cited : (18)
|
|
References (0)
|
